{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:39:28Z","timestamp":1791923968994,"version":"4.3.4"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Hidradenitis suppurativa (HS) is a common, debilitating inflammatory skin disease linked to immune dysregulation and abnormalities in follicular structure and function. Several studies have characterized the transcriptomic profile of affected and unaffected skin in small populations. In this study of 20 patients, RNA from lesional and matching non-lesional skin biopsies in 20 subjects were used to identify an expression-based HS disease signature. This was followed by differential expression and pathway enrichment analyses, as well as jointly reanalyzing our findings with previously published transcriptomic profiles. We establish an RNA-Seq based HS expression disease signature that is mostly consistent with previous reports. Bulk-RNA profiles from 104 subjects in 7 previously reported data sets identified a disease signature of 118 differentially regulated genes compared to three control data sets from non-lesional skin. We confirmed previously reported expression profiles and further characterized dysregulation in complement activation and host response to bacteria in disease pathogenesis. Changes in the transcriptome of lesional skin in this cohort of HS patients is consistent with smaller previously reported populations. The findings further support the significance of immune dysregulation, in particular with regard to bacterial response mechanisms. Joint analysis of this and previously reported cohorts indicate a remarkably consistent expression profile.<\/jats:p>","DOI":"10.1371\/journal.pone.0284047","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T17:30:53Z","timestamp":1680802253000},"page":"e0284047","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["A Hidradenitis Suppurativa molecular disease signature derived from patient samples by high-throughput RNA sequencing and re-analysis of previously reported transcriptomic data sets"],"prefix":"10.1371","volume":"18","author":[{"given":"Johannes M.","family":"Freudenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Traini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak K.","family":"Rajpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3201-4637","authenticated-orcid":true,"given":"Christopher J.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"issue":"5 Suppl 1","key":"pone.0284047.ref001","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaad.2015.07.052","article-title":"Hidradenitis suppurativa: Epidemiology and scope of the problem","volume":"73","author":"GB Jemec","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"pone.0284047.ref002","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","article-title":"Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis","volume":"77","author":"A Garg","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"pone.0284047.ref003","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","volume":"178","author":"JR Ingram","year":"2018","journal-title":"Br J Dermatol"},{"issue":"6","key":"pone.0284047.ref004","doi-asserted-by":"crossref","DOI":"10.5070\/D3236035391","article-title":"Examining the race-specific prevalence of hidradenitis suppurativa at a large academic center; results from a retrospective chart review","volume":"23","author":"T Vaidya","year":"2017","journal-title":"Dermatol Online J"},{"issue":"1","key":"pone.0284047.ref005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"R Sabat","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"pone.0284047.ref006","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","article-title":"Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis","volume":"82","author":"SR Goldburg","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"pone.0284047.ref007","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"AB Kimball","year":"2012","journal-title":"Ann Intern Med"},{"issue":"5","key":"pone.0284047.ref008","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa","volume":"375","author":"AB Kimball","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0284047.ref009","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bjd.18983","article-title":"Evidence for a \u2019window of opportunity\u2019 in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study","volume":"184","author":"AV Marzano","year":"2021","journal-title":"Br J Dermatol"},{"issue":"1","key":"pone.0284047.ref010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.det.2015.08.004","article-title":"Inflammatory Mechanisms in Hidradenitis Suppurativa","volume":"34","author":"G Kelly","year":"2016","journal-title":"Dermatol Clin"},{"issue":"3","key":"pone.0284047.ref011","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/exd.12098","article-title":"Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology","volume":"22","author":"BC Melnik","year":"2013","journal-title":"Exp Dermatol"},{"issue":"3","key":"pone.0284047.ref012","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/jid.2012.372","article-title":"gamma-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis","volume":"133","author":"AE Pink","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"4","key":"pone.0284047.ref013","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"C Schlapbach","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"pone.0284047.ref014","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12788\/j.sder.2017.017","article-title":"Pathophysiology of hidradenitis suppurativa","volume":"36","author":"LK Hoffman","year":"2017","journal-title":"Semin Cutan Med Surg"},{"key":"pone.0284047.ref015","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3389\/fimmu.2019.00892","article-title":"An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis","volume":"10","author":"PM Tricarico","year":"2019","journal-title":"Front Immunol"},{"key":"pone.0284047.ref016","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents","author":"L Matusiak","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"pone.0284047.ref017","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents?","volume":"89","author":"L Matusiak","year":"2009","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"pone.0284047.ref018","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00403-017-1769-5","article-title":"IL-36 cytokines are increased in acne and hidradenitis suppurativa","volume":"309","author":"R Di Caprio","year":"2017","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"pone.0284047.ref019","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00011-020-01381-7","article-title":"Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis","volume":"69","author":"BE Rumberger","year":"2020","journal-title":"Inflamm Res"},{"issue":"6","key":"pone.0284047.ref020","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","article-title":"The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction","volume":"139","author":"E Witte-Handel","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"10","key":"pone.0284047.ref021","doi-asserted-by":"crossref","DOI":"10.3390\/biom12101371","article-title":"Transcriptome Meta-Analysis Confirms the Hidradenitis Suppurativa Pathogenic Triad: Upregulated Inflammation, Altered Epithelial Organization, and Dysregulated Metabolic Signaling","volume":"12","author":"A de Oliveira","year":"2022","journal-title":"Biomolecules"},{"issue":"9","key":"pone.0284047.ref022","doi-asserted-by":"crossref","first-page":"e0203672","DOI":"10.1371\/journal.pone.0203672","article-title":"Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature","volume":"13","author":"LK Hoffman","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"pone.0284047.ref023","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jid.2016.04.036","article-title":"Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa","volume":"136","author":"C Hotz","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"6","key":"pone.0284047.ref024","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/bjd.14371","article-title":"Gene expression profiling of skin and blood in hidradenitis suppurativa","volume":"174","author":"JL Blok","year":"2016","journal-title":"Br J Dermatol"},{"issue":"2","key":"pone.0284047.ref025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jaad.2017.03.016","article-title":"Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa","volume":"77","author":"M Dany","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"pone.0284047.ref026","doi-asserted-by":"crossref","first-page":"e0216249","DOI":"10.1371\/journal.pone.0216249","article-title":"The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin","volume":"14","author":"M Coates","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"pone.0284047.ref027","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/jdv.16147","article-title":"Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa","volume":"34","author":"CC Zouboulis","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"pone.0284047.ref028","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/ced.13959","article-title":"Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis","volume":"44","author":"VK Shanmugam","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"19","key":"pone.0284047.ref029","article-title":"Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-alpha therapy","volume":"5","author":"MM Lowe","year":"2020","journal-title":"JCI Insight"},{"issue":"7","key":"pone.0284047.ref030","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/jdv.16264","article-title":"Apocrine glands are bystanders in hidradenitis suppurativa and their involvement is gender specific","volume":"34","author":"CC Zouboulis","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"19","key":"pone.0284047.ref031","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139930","article-title":"Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis","volume":"5","author":"JE Gudjonsson","year":"2020","journal-title":"JCI Insight"},{"issue":"12","key":"pone.0284047.ref032","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.jid.2020.04.011","article-title":"Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4","volume":"140","author":"CA Penno","year":"2020","journal-title":"J Invest Dermatol"},{"key":"pone.0284047.ref033","doi-asserted-by":"crossref","first-page":"1060547","DOI":"10.3389\/fimmu.2022.1060547","article-title":"A rare loss-of-function genetic mutation suggest a role of dermcidin deficiency in hidradenitis suppurativa pathogenesis","volume":"13","author":"PM Tricarico","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"pone.0284047.ref034","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"MI Love","year":"2014","journal-title":"Genome Biol"},{"issue":"1","key":"pone.0284047.ref035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"YH Y. Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society Series B (Methodological)"},{"issue":"7","key":"pone.0284047.ref036","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/jid.2010.36","article-title":"Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models","volume":"130","author":"JE Gudjonsson","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"9","key":"pone.0284047.ref037","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.drudis.2014.03.015","article-title":"Integrative clinical transcriptomics analyses for new therapeutic intervention strategies: a psoriasis case study","volume":"19","author":"XA Qu","year":"2014","journal-title":"Drug Discov Today"},{"key":"pone.0284047.ref038","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12864-015-1508-2","article-title":"Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN","volume":"16","author":"M Keermann","year":"2015","journal-title":"BMC Genomics"},{"key":"pone.0284047.ref039","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1471-2105-10-234","article-title":"CLEAN: CLustering Enrichment ANalysis","volume":"10","author":"JM Freudenberg","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"pone.0284047.ref040","doi-asserted-by":"crossref","first-page":"2040622319830646","DOI":"10.1177\/2040622319830646","article-title":"Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms","volume":"10","author":"JW Frew","year":"2019","journal-title":"Ther Adv Chronic Dis"},{"issue":"3","key":"pone.0284047.ref041","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/bjd.17426","article-title":"Complement, hidradenitis suppurativa and pathogen-driven positive selection","volume":"180","author":"JW Frew","year":"2019","journal-title":"Br J Dermatol"},{"issue":"2","key":"pone.0284047.ref042","first-page":"413","article-title":"Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?","volume":"179","author":"T Kanni","year":"2018","journal-title":"Br J Dermatol"},{"key":"pone.0284047.ref043","volume-title":"Handbook of Research Synthesis and Meta-Analysis","author":"BW M.C. Bushman","year":"2009"},{"key":"pone.0284047.ref044","article-title":"Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis","author":"VK Shanmugam","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"19","key":"pone.0284047.ref045","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1242\/dev.109231","article-title":"Involvement of Wnt, Eda and Shh at defined stages of sweat gland development","volume":"141","author":"CY Cui","year":"2014","journal-title":"Development"},{"issue":"7","key":"pone.0284047.ref046","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.jid.5700376","article-title":"Epithelial stem cells: a folliculocentric view","volume":"126","author":"G. Cotsarelis","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"6","key":"pone.0284047.ref047","doi-asserted-by":"crossref","first-page":"e0130522","DOI":"10.1371\/journal.pone.0130522","article-title":"Compartmentalized Cytokine Responses in Hidradenitis Suppurativa","volume":"10","author":"T Kanni","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"pone.0284047.ref048","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"G Kelly","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"pone.0284047.ref049","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/exd.13482","article-title":"Elevated levels of the antimicrobial peptide LL-37 in hidradenitis suppurativa are associated with a Th1\/Th17 immune response","volume":"27","author":"R Thomi","year":"2018","journal-title":"Exp Dermatol"},{"key":"pone.0284047.ref050","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.12688\/f1000research.17267.1","article-title":"A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa","volume":"7","author":"JW Frew","year":"2018","journal-title":"F1000Res"},{"issue":"2","key":"pone.0284047.ref051","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa","volume":"186","author":"K Wolk","year":"2011","journal-title":"J Immunol"},{"issue":"6","key":"pone.0284047.ref052","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-alpha and IL-1beta","volume":"164","author":"HH van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"issue":"5","key":"pone.0284047.ref053","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/09546634.2017.1395806","article-title":"Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials","volume":"29","author":"M Maarouf","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"pone.0284047.ref054","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.det.2015.08.013","article-title":"Antibiotic Treatment of Hidradenitis Suppurativa","volume":"34","author":"V Bettoli","year":"2016","journal-title":"Dermatol Clin"},{"issue":"2","key":"pone.0284047.ref055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jac\/dkv361","article-title":"Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients","volume":"71","author":"O Join-Lambert","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pone.0284047.ref056","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa","volume":"222","author":"O Join-Lambert","year":"2011","journal-title":"Dermatology"},{"issue":"10","key":"pone.0284047.ref057","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/exd.14451","article-title":"Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction?","volume":"30","author":"DGW Johnston","year":"2021","journal-title":"Exp Dermatol"},{"issue":"1","key":"pone.0284047.ref058","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/exd.14056","article-title":"Integrating complement into the molecular pathogenesis of Hidradenitis Suppurativa","volume":"29","author":"D Grand","year":"2020","journal-title":"Exp Dermatol"},{"key":"pone.0284047.ref059","article-title":"The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls","author":"HC Ring","year":"2017","journal-title":"JAMA dermatology"},{"issue":"2","key":"pone.0284047.ref060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cid\/cix285","article-title":"The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study","volume":"65","author":"H Guet-Revillet","year":"2017","journal-title":"Clin Infect Dis"},{"key":"pone.0284047.ref061","article-title":"The microbiome of tunnels in hidradenitis suppurativa patients","author":"HC Ring","year":"2019","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"issue":"6","key":"pone.0284047.ref062","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.jaci.2020.12.651","article-title":"Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa","volume":"147","author":"K Navrazhina","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"pone.0284047.ref063","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with Bioconductor","volume":"12","author":"W Huber","year":"2015","journal-title":"Nat Methods"},{"issue":"Database issue","key":"pone.0284047.ref064","first-page":"D991","article-title":"NCBI GEO: archive for functional genomics data sets\u2014update","volume":"41","author":"T Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"pone.0284047.ref065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2014analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"L Gautier","year":"2004","journal-title":"Bioinformatics"},{"issue":"20","key":"pone.0284047.ref066","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1093\/nar\/gni179","article-title":"Evolving gene\/transcript definitions significantly alter the interpretation of GeneChip data","volume":"33","author":"M Dai","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"pone.0284047.ref067","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"pone.0284047.ref068","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"GK Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T21:29:55Z","timestamp":1729200595000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284047"}},"subtitle":[],"editor":[{"given":"Michel","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":68,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0284047","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]}}}